Company snapshot
Market Cap
$41B
Large-cap2016 — today
10-Year Price
+388%
2016 — today
52-Week Range
$504.70$766.68
Current $504.70· 0%
Featured in rankings
S&P500NASDAQMost Undervalued Healthcare StocksMost Undervalued Value StocksMost Undervalued Growth StocksCheapest Large-Cap Stocks
Rankings recomputed after each US market close — see where IDXX stands against peers.
Similar companies
| Company | P/E | Div yield |
|---|---|---|
| ONCBeOne Medicines Ltd. | 4.8 | — |
| AAgilent Technologies, Inc. | 28.9 | 0.5% |
| RVMDRevolution Medicines, Inc. | -23.0 | — |
| TEVATeva Pharmaceutical Industries Limited | 61.8 | — |
| NTRANatera, Inc. | -241.9 | — |
| ALNYAlnylam Pharmaceuticals, Inc. | 42.0 | — |
| EWEdwards Lifesciences Corporation | 48.5 | — |
| BDXBecton, Dickinson and Company | 53.6 | 2.2% |
Healthcare companies of comparable size — each one shown against its own 10-year range, not a sector average. Browse all stocks we cover.
Valuation in context
P/E ratio
35.7
Near historic low
Near historic low — last 10 years
Sector median 24.4above sector
P/B ratio
25.2
Below average
Below the 10-year average
Sector median 2.5above sector
EV / EBITDA
25.7
Near historic low
Near historic low — last 10 years
Sector median 15.2above sector
PEG ratio
3.3
Above average
Pricier than usual over the last 10 years
Sector median 1.4above sector
FCF Yield
3.1%
Near historic high
Near historic highs — last 10 years
Sector median -9.6%above sector